Respiratory Syncytial Virus (RSV) Update
Open Access
Abstract
Since the initial identification of respiratory syncytial virus (RSV) in 1956, much has been learned about the epidemiological impact and clinical manifestations of RSV infectionsKeywords
This publication has 7 references indexed in Scilit:
- Respiratory syncytial virus vaccine: where are we now and what comes next?Expert Opinion on Biological Therapy, 2018
- Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in ChildrenInfectious Diseases and Therapy, 2018
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling studyThe Lancet, 2017
- RSV Policy Statement —Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 2014;134(2):415–420Pediatrics, 2014
- Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus InfectionPediatrics, 2014
- Respiratory syncytial virus prevention and therapy: Past, present, and futurePediatric Pulmonology, 2010
- Risk of Primary Infection and Reinfection With Respiratory Syncytial VirusArchives of Pediatrics & Adolescent Medicine, 1986